Alaska Permanent Fund Corp Makes New Investment in The Clorox Company (NYSE:CLX)

Alaska Permanent Fund Corp acquired a new position in The Clorox Company (NYSE:CLXFree Report) in the 1st quarter, Holdings Channel reports. The institutional investor acquired 411 shares of the company’s stock, valued at approximately $63,000.

Several other hedge funds and other institutional investors have also bought and sold shares of CLX. Rafferty Asset Management LLC raised its stake in Clorox by 11.2% in the 3rd quarter. Rafferty Asset Management LLC now owns 9,231 shares of the company’s stock worth $1,210,000 after purchasing an additional 929 shares in the last quarter. Envestnet Asset Management Inc. raised its position in shares of Clorox by 27.2% in the 3rd quarter. Envestnet Asset Management Inc. now owns 260,276 shares of the company’s stock valued at $34,112,000 after buying an additional 55,620 shares in the last quarter. LPL Financial LLC raised its position in shares of Clorox by 1.5% in the 3rd quarter. LPL Financial LLC now owns 276,835 shares of the company’s stock valued at $36,282,000 after buying an additional 4,035 shares in the last quarter. Mariner LLC raised its position in shares of Clorox by 19.1% in the 3rd quarter. Mariner LLC now owns 94,412 shares of the company’s stock valued at $12,374,000 after buying an additional 15,112 shares in the last quarter. Finally, Federated Hermes Inc. raised its position in shares of Clorox by 16.4% in the 3rd quarter. Federated Hermes Inc. now owns 4,744 shares of the company’s stock valued at $622,000 after buying an additional 670 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Up 0.7 %

CLX opened at $136.64 on Friday. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.14. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The firm has a market capitalization of $16.97 billion, a price-to-earnings ratio of 70.80, a PEG ratio of 2.18 and a beta of 0.39. The company’s 50 day moving average price is $137.62 and its two-hundred day moving average price is $144.02.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period in the previous year, the firm posted $1.51 EPS. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. As a group, research analysts predict that The Clorox Company will post 5.91 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently commented on CLX shares. DA Davidson restated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research report on Wednesday, April 17th. The Goldman Sachs Group started coverage on shares of Clorox in a research report on Friday, March 1st. They issued a “sell” rating and a $140.00 target price for the company. Barclays dropped their target price on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a research report on Thursday, May 2nd. Jefferies Financial Group raised shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target on the stock in a report on Tuesday, March 26th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $160.00 price target on shares of Clorox in a report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. According to MarketBeat, Clorox presently has an average rating of “Hold” and an average target price of $146.43.

View Our Latest Stock Report on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.